Abstract
We report a case of neonatal lupus erythematosus (NLE) with congenital heart block and severe myocardial failure, which was followed from the 25th week of gestation because of fetal bradycardia. The child was delivered at the 37th week of gestation by elective cesarean section because of echocardiographically documented heart enlargement, pericardial effusion and moderate insufficiency of the mitral and tricuspid valves. In spite of immediate pacing, intubation and supportive treatment, the newborn developed progressive heart failure. Echocardiography showed endocarditis of the mitral valve and diffuse myocarditis. The heart failure resolved under steroid treatment. Our experience supports the early use of steroids in treating myocarditis due to NLE. Intrauterine steroid treatment in the presence of fetal hydrops and congenital heart block is discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Litsey SE, Noonan JA, O'Connor WN, Cottril CM, Mitchell B (1985) Maternal connective tissue disease and congenital heart block demonstration of immunoglobulin in cardiac tissue. N Engl J Med 312:98–100
Mc Cune AB, Weston WL, Lee LA (1987) Maternal and fetal outcome in neonatal lupus erythematosus. Ann Internal Med 106:518–523
Buyon JP, Swersky SA, Fox HE, Bierman FZ, Winchester RJ (1987) Intrauterine therapy for presumptive fetal myocarditis with acquired heart block due to SLE. Arthritis Rheum 30:44–49
Biermann FZ, Baxi L, Jaffe I, Driscoll J (1988) Fetal hydrops and congenital heart block: response to maternal steroid therapy. J Pediatr 112:646–648
Jordan JM, Valenstein P, Kredich DW (1989) Systemic lupus erythematosus Libmann Sachs endocarditis in a 9 month old infant with neonatal lupus erythematosus and congenital heart block. Pediatrics 84:574–578
Lockshin MD, Bonfa E, Elkon K, Druzin ML (1988) Neonatal lupus risk to newborn of mothers with SLE. Arthritis Rheum 31:697–701
Ramsey-Goldmann R, Hom D, Shyong Deng J, Ziegler GC, Kahl LE, Steen VD, La Porte RE, Medsger TA (1986) Anti SS-A antibodies and fetal outcome in maternal systemic lupus erythematosus. Arthritis Rheum 29:1269–1273
Lubbe WF, Liggins GC (1985) Lupus anticoagulans and pregnancy. Am J Obstet Gynecol 153:322–327
Mc Hugh NL, Relly PA, Mc Hugh LA (1989) Pregnancy outcome and autoantibodies in connective tissue disease. J Rheumatol 16:42–46
Scott JS, Maddison PJ, Taylor PV et al. (1983) Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med 309:209–212
Lubbe WF, Butler WS, Palmer SJ, Liggins GC (1983) Fetal survival after prednisone suppression of maternal lupus anticoagulant. Lancet 18: 1361–1363
Branch DW, Scott JR, Kochenour NK, Hershgold E (1985) Obstetric complications associated with the lupus anticoagulant. N Engl J Med 21:1322–1326
Herremann G, Galesecsky N (1985) Maternal connective tissue disease and congenital heart block (letter). N Engl J Med 312:1329
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ferrazzini, G., Fasnacht, M., Arbenz, U. et al. Neonatal lupus erythematosus with congenital heart block and severe heart failure due to myocarditis and endocardititis of the mitral valve. Intensive Care Med 22, 464–466 (1996). https://doi.org/10.1007/BF01712168
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01712168